However, we did not find any association between CCBE1 methylation and clinicopathological parameters, including FIGO stage, tumour grade or age at diagnosis, nor any evidence that CCBE1 methylation could predict earlier disease recurrence. This evidence concerns the gene CCBE1 and neoplasm.